KNGOP-1

N/A

Report date: 2025/01/26 17:35:56

NME

Base Information

Drug NameKNGOP-1

Drug Alias NameKGOP-1/KGNOP-3 bifunctional hybrid peptide (INSERM/Universite de Sherbrooke/l’Universite Paris Descartes/University of Innsbruck/Universite Denis Diderot)mu-opioid receptor agonist/nociceptin receptor antagonist (INSERM/Universite de Sherbrooke/l’Universite Paris Descartes/University of Innsbruck/Universite Denis Diderot)KNGOP-1

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionMu opioid receptor agonistsNociceptin receptor antagonists

TargetsMu opioid receptorNociceptin receptor

Therapy Area/IndicationsNeuralgia

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustriaFrance

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesInstitut National De La Sante Et De La Recherche Medicale

China Registration ClassN/A

Develop Information

Active CompaniesInstitut National De La Sante Et De La Recherche Medicale Université Paris Descartes Université Paris Diderot +[5]

Inactive CompaniesN/A

Active IndicationsNeuralgia

Inactive IndicationsN/A

Other Information

ATC CodeN/A